ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors.

Victoria Roulstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.